BIOTECH MARKET RESEARCH $OM | Ep. 1057
Outset Medical
BowTiedBiotech
Daily Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends
Subscribe:.rss.atom.json.md.m3u.pls
Overdue Last read · last published · next check
Last read 1 day ago, longer than this feed's 12 hours schedule.
Latest episodes
Saves to your Listen queue, to pick up on another day or another device.
Your Weekly Biotech News Fix | Ep. 1056
The week of 8.10.2026
The New Drug Developer Has a Balance Sheet | Ep. 1055
How private capital is changing which drugs get funded, who keeps the upside, and what investors should watch next.
Strategic Flexibility in FDA Cell and Gene Therapy Regulation | Ep. 1054
FDA Overhauls Gene Therapy Manufacturing Rules
BIOTECH MARKET RESEARCH $AMLX | Ep. 1053
Amylyx Pharmaceuticals
Programmable Immunity | Ep. 1052
The Real Opportunity in In-Vivo CAR Therapies
BowTiedBiotech: A Constructive Week for the Sector | Ep. 1051
Capital surges in an unforgiving biotech market
Your Weekly Biotech News Fix | Ep. 1050
The week of 8.3.2026
The Drug Supply Chain Is Running Out of Water | Ep. 1049
Europe’s drought is turning rivers, cooling systems, and industrial water into hidden constraints on therapeutic development
Breaking the Career Ladder: The Future of Entry-Level Work | Ep. 1048
How AI breaks the corporate ladder
The Last Shot Strategy | Ep. 1047
What Happens When Biotech Goes Virtual to Survive
Biotech Market Review: Clinical Outcomes and Commercial Execution | Ep. 1046
Scientific Theory Versus Brutal Market Reality
Your Weekly Biotech News Fix | Ep. 1045
The week of 7.27.2026
Internal Innovation or Strategic Sourcing? | Ep. 1043
Rethinking Pharma's Growth Engine
BIOTECH MARKET RESEARCH $SLN | Ep. 1044
SIlence Therapeutics
Biotech Pulse: Clinical Trials, M&A, and Regulatory Risk | Ep. 1042
The Billion Dollar Biotech Reality Check
Your Weekly Biotech News Fix | Ep. 1041
The week of 7.20.2026
The Peptide Underground Is Running Biotech’s Cheapest Human Experiment | Ep. 1040
The FDA crackdown on compounded peptides could reveal the next real therapeutic platform hiding inside the wellness market.
The Invisible Factory: The Hidden Biotech Supply Chain | Ep. 1039
Biotech Companies Do Not Make Drugs
Liquidity, Beta, and the Biotech Edge | Ep. 1038
Finding Alpha When the Herd Gets Whiplashed
Inflammation at the Helm | Ep. 1037
Reprogramming the Brain’s Immune Axis to Rewrite Neurodegeneration